NCT03408093View on ClinicalTrials.gov

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

CompletedOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

February 3, 2009

Primary Completion Date

March 30, 2010

Study Completion Date

March 30, 2010

Conditions

Multiple Sclerosis

Interventions

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Interferon beta-1b (INFb-1b) was used at the standard dose of 250 mg/ml.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY